Chronic Low Back Pain: Current Pharmacotherapeutic Therapies and a New Biological Approach
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023728%3A_____%2F19%3AN0000034" target="_blank" >RIV/00023728:_____/19:N0000034 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11120/19:43918249
Výsledek na webu
<a href="http://www.eurekaselect.com/162091/article" target="_blank" >http://www.eurekaselect.com/162091/article</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.2174/0929867325666180514102146" target="_blank" >10.2174/0929867325666180514102146</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Chronic Low Back Pain: Current Pharmacotherapeutic Therapies and a New Biological Approach
Popis výsledku v původním jazyce
Chronic low back pain (CLBP) syndrome represents one of the leading causes of long-term disability worldwide. The prevalence of CLBP has been rising significantly in relation to increasing average life expectancy. CLBP results from chronification of acute low back pain. There are many factors contributing to the CLBP crisis; common etiopathogenetic factors include e.g., functional blockage of intervertebral joints. The treatment of CLBP is complex. An important part of treatment consists of pain pharmacotherapy, for which several groups of drugs are used. The problem lies in the side effects of many of these traditionally used medications. Therefore, new and safer treatment methods are being sought. Innovative options for CLBP pharmacology include injections containing collagen, which can be combined with other traditionally used drugs, which helps reduce dosages and increase the overall safety of CLBP therapy.
Název v anglickém jazyce
Chronic Low Back Pain: Current Pharmacotherapeutic Therapies and a New Biological Approach
Popis výsledku anglicky
Chronic low back pain (CLBP) syndrome represents one of the leading causes of long-term disability worldwide. The prevalence of CLBP has been rising significantly in relation to increasing average life expectancy. CLBP results from chronification of acute low back pain. There are many factors contributing to the CLBP crisis; common etiopathogenetic factors include e.g., functional blockage of intervertebral joints. The treatment of CLBP is complex. An important part of treatment consists of pain pharmacotherapy, for which several groups of drugs are used. The problem lies in the side effects of many of these traditionally used medications. Therefore, new and safer treatment methods are being sought. Innovative options for CLBP pharmacology include injections containing collagen, which can be combined with other traditionally used drugs, which helps reduce dosages and increase the overall safety of CLBP therapy.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30226 - Rheumatology
Návaznosti výsledku
Projekt
—
Návaznosti
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2019
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
CURRENT MEDICINAL CHEMISTRY
ISSN
0929-8673
e-ISSN
1875-533X
Svazek periodika
26
Číslo periodika v rámci svazku
6
Stát vydavatele periodika
AE - Spojené arabské emiráty
Počet stran výsledku
8
Strana od-do
1019-1026
Kód UT WoS článku
000467733300007
EID výsledku v databázi Scopus
2-s2.0-85066472141